IP Library Patent Application 17955413
Patent Application
App. No. 17/955,413

PREBIOTIC FORMULATIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/955,413
Abstract

Provided herein are compositions comprising a biocompatible microsphere, a biofilm-generating probiotic bacterium, a prebiotic, and/or a prebiofilmic. Methods for preparing and formulating the compositions and methods for treating or preventing a disease using the compositions are also provided.

Claims (12)

1 - 71 . (canceled)

72 . A method of treating depression or anxiety in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition comprising: a strain of Lactobacillus reuteri (“ L. reuteri ”) that expresses glucosyltransferase (GTF) protein; a biocompatible microsphere; and a water-soluble carbohydrate, thereby treating depression or anxiety.

73 . The method of claim 72 , wherein the L. reuteri is adhered to the biocompatible microsphere.

74 . The method of claim 72 , wherein the strain of L. reuteri is selected from the group consisting of ATCC 23272 , L. reuteri strain 100-23, ATCC PTA 6475, ATCC 55730, DSM 17938 and combination(s) thereof.

75 . The method of claim 72 , wherein the water-soluble carbohydrate is selected from the group consisting of maltose, sucrose, and combinations thereof.

76 . The method of claim 72 , wherein the biocompatible microsphere has a diameter of about 1 microns to about 100 microns.

77 . The method of claim 72 , wherein the biocompatible microsphere comprises dextran cross-linked with epichlorohydrin.

78 . The method of claim 72 , wherein the subject also has a gastrointestinal disorder.

79 . The method of claim 72 , wherein administration comprises an oral administration.

80 . The method of claim 72 , wherein the composition is administered to provide from about 1×10 7 to about 1×10 11 CFU/ml of L. reuteri.

81 . The method of claim 72 , wherein the composition is administered in a single dose.

82 . The method of claim 72 , wherein the composition is administered in multiple doses.